loading

Processa Pharmaceuticals Inc Azioni (PCSA) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Operating Income/Loss
38.77%
-3.9508
-2.847 -2.7347 -3.4249 -3.082
Income/Loss From Continuing Operations Before Tax
38.79%
-3.9339
-2.8344 -2.7287 -3.3847 -3.0103
Income/Loss From Continuing Operations After Tax
38.79%
-3.9339
-2.8344 -2.7287 -3.3847 -3.0103
Net Income/Loss
38.79%
-3.9339
-2.8344 -2.7287 -3.3847 -3.0103
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
63.43%
15.57
9.5268 0.15 3.276 2.9833
Diluted Average Shares
63.43%
15.57
9.5268 0.15 3.276 2.9833
Basic Earnings Per Share
16.67%
-0.25
-0.30 -0.74 -1.03 -1.01
Diluted Earnings Per Share
16.67%
-0.25
-0.30 -0.74 -1.03 -1.01
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$36.56
price up icon 0.14%
$87.23
price down icon 0.30%
$26.09
price down icon 3.84%
$128.75
price up icon 0.38%
$114.09
price up icon 0.58%
biotechnology ONC
$326.70
price up icon 1.16%
Capitalizzazione:     |  Volume (24 ore):